Analysis of influencing factors of early poor recovery of liver function after liver transplantation with organ donation for cardiac death
YANG Yang1, JIAO Ning1,2, CHEN Xinguo1, HAN Yanping3, LI Ziqiang1, ZHANG Qing1
1. Department of Organ Transplantation, Third Medical Center, General Hospital of Chinese PLA, Beijing 100039, China; 2. Weifang Medical University,Weifang 261035,China; 3. Eastern Medical District of Chinese PLA General Hospital. Beijing 101149, China
Abstract:Objective To assessment the risk factors on poor early liver function recovery. of recipient after liver transplantation (LT) using allografts from donation after cardiac death (DCD) or brain and cardiac death(DBCD)donors.Methods In this retrospectively study, 211 liver transplantation using grafts from DCD or DBCD donors were performed at the Third Medical Center, General Hospital of Chinese PLA from September 2013 to January 2017. We collected data of recipient and donor including gender, age, primary disease, ABO blood type, body mass index (BMI), medical history (fatty liver, hypertension), ICU hospitalization time, mechanical ventilation time, warm ischemia time, cold ischemia time, intraoperative blood loss, operation time, Model for End-Stage Liver Disease (MELD) score and indexes of routine laboratory test, et al. Statistical analysis using the chi-square test, multivariate step-wise Cox regression were performed.Results Of the 211 patients, intraoperative blood loss (P=0.046), BMI (P=0.035), MELD score (P=0.000), and donor age (P=0.047), male gender (P=0.028), serum potassium level (P=0.001), extubation to cardiac arrest (P=0.004), as well as donor ICU hospitalization time (P=0.022) all related to the early liver dysfunction after LT. Multivariate step-wise Cox regression showed that the intraoperative blood loss(P=0.001,HR=12.512,95%CI: 2.679-58.434), MELD score(P=0.021,HR=3.991,95%CI: 1.237-12.876)were independent prognostic risk factors.Conclusions Controlling intraoperative blood loss and selecting receptors with MELD score <25 may further improve the early liver function and prognosis of recipients after LT.
杨洋, 矫宁, 陈新国, 韩艳萍, 李自强, 张庆. 心脏死亡者供肝移植术后受体早期肝功能恢复不良的影响因素分析[J]. 武警医学, 2021, 32(9): 790-794.
YANG Yang, JIAO Ning, CHEN Xinguo, HAN Yanping, LI Ziqiang, ZHANG Qing. Analysis of influencing factors of early poor recovery of liver function after liver transplantation with organ donation for cardiac death. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(9): 790-794.
Croome K P, Taner C B. The changing landscapes in DCD liver transplantation[J]. Curr Transplant Rep,2020, 7:194-204
[5]
Schlegel A, Muller X, Kalisvaart M, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation[J]. J Hepatol, 2019,70(1):50-57.
[6]
Duan X, Yan L, Shen Y, et al. Outcomes of liver transplantation using moderately steatotic liver from donation after cardiac death (DCD)[J]. Ann Transl Med, 2020,8(18):1188.
Dutkowski P, Schlegel A, de Oliveira M, et al. HOPE for human liver grafts obtained from donors after cardiac death[J]. J Hepatol,2014,60(4): 765-772.
[10]
Yu J, Murakami M, Aoki T, et al. Oxygenated static preservation of donation after cardiac death liver grafts improves hepatocyte viability and function[J]. Eur Surg Res,2016,56(1-2): 1-18.
[11]
Watson C J E, Hunt F, Messer S, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival[J]. Am J Transplant, 2019, 19(6):1745-1758.
Kong L, Lv T, Jiang L,et al. Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis[J]. BMC Surg, 2020,20(1):290.
[15]
Ibrahim S, Chen C L, Lin C C, et al. Intraoperative blood loss is a risk factor for complications in donors after living donor hepatectomy[J]. Liver Transpl, 2006,12(6):950-957.
[16]
Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, et al. Model for end stage Liver Disease (MELD) and child-turcotte-pugh (CTP) scores: ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions[J]. Arch Iran Med, 2014, 17(2):118-121.
Ling Q, Wang K, Lu D, et al. Major influence of renal function on hyperlipidemia after living donor liver transplantation[J]. World J Gastroenterol, 2012,18(47):7033-9.
[19]
Li P,Liang X, Xu S, et al. A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure[J]. Sci Rep, 2021,11(1):2975.
[20]
Croome K P, Lee D D, Keaveny A P, et al. Improving national results in liver transplantation using grafts from donation after cardiac death donors[J]. Transplantation, 2016, 100(12):2640-2647.